Basis of Presentation - Schdule of Condensed Consolidated Financial Statements (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Total current assets	$ 318,589		$ 320,673
Total assets	395,083		400,308
Total current liabilities	3,003,259		2,600,708
Total liabilities	3,003,259
Total stockholders' deficiency	(2,608,176)		(2,200,400)
Total liabilities and stockholders' deficiency	395,083		400,308
Revenues	74,534
Total operating expenses	670,692	$ 2,412,196
Loss from operations	(596,158)	(2,412,196)
Net loss	(727,952)	(1,380,710)	(2,707,535)
Net loss attributable to common stockholders	$ (731,150)	$ (2,591,088)
Net loss per common share - basic and diluted	$ 0.00	$ (.02)
Net cash used in operating activities	$ (200,403)	$ (313,759)	(885,869)
Net cash used in investing activities	(2,497)	(1,925)
Net cash provided by financing activities	194,300	613,264
Net increase (decrease) in cash	(8,600)	297,580
Balance at beginning of period	162,752	14,352	14,352
Balance at end of period	154,152	$ 311,932	162,752
As Reported [Member]
Total current assets	318,589
Total assets	395,083
Total current liabilities	2,873,439
Total liabilities	2,873,439
Total stockholders' deficiency	(2,478,356)
Total liabilities and stockholders' deficiency	395,083
Revenues	74,534
Total operating expenses	540,872
Loss from operations	(466,338)
Net loss	(598,132)
Net loss attributable to common stockholders	$ (601,330)
Net loss per common share - basic and diluted	$ (0.00)
Net cash used in operating activities	$ (200,403)
Net cash used in investing activities	(2,497)
Net cash provided by financing activities	194,300
Net increase (decrease) in cash	(8,600)
Balance at beginning of period	162,752
Balance at end of period	$ 154,152		$ 162,752